Schedule 13G ownership disclosure

COCRYSTAL PHARMA INC

Security class unavailable · CUSIP: 19188J300

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,949,980
Percent of class
5.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-21-000013
Form type
SC 13G
Filer
Cocrystal Pharma, Inc.
CIK
CIK 1412486
Filed
Feb 10, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub